Opioid Use Disorder
📧 Sign up to get email alerts when something new happens for Opioid Use Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Sex and Female Empowerment [NA]
This clinical trial update notes the completion of a study sponsored by the University of North Carolina focusing on sex and female empowerm…
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: Evaluation of a Computerized Opioid Overdose Prevention Program [NA]
This clinical trial update reports completion and posted results of a study evaluating a computerized opioid overdose prevention program, co…
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: Investigation of the Effect of Intravenous Lidocaine Infusion on Postoperative Pain Treatment and Bowel Function in Robotic Bowel Surgery [Phase 4]
Phase 4 clinical trial investigating intravenous lidocaine infusion for postoperative pain and bowel function after robotic bowel surgery.
-
FDA approval · 2017-09-19FDA Approved: SUBOXONE — Supplemental Application (INDIVIOR INC.)
FDA approves a supplemental application for Suboxone (buprenorphine hydrochloride, naloxone hydrochloride) from Indivior Inc. The action ref…
-
FDA approval · 2017-09-08FDA Approved: ZUBSOLV — Supplemental Application (Orexo US, Inc.)
The FDA has approved a supplemental application for ZUBSOLV (buprenorphine/naloxone) submitted by Orexo US, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers [Phase 2]
Phase 2 trial assessing the effect of ibudilast on oxycodone self-administration in individuals with opioid use disorder; study completed wi…
-
CLINICAL_TRIALS research · 2017-07-25Clinical Trial Update: Facilitating MAT Acceptance & Implementation in Problem Solving & Felony Courts [Phase 1, Phase 2]
A Phase 1/2 clinical trial update exploring strategies to facilitate acceptance and implementation of medication-assisted treatment for opio…
-
CLINICAL_TRIALS withdrawal · 2017-07-24Clinical Trial Update: The Mobile Monitoring of Vital Signs in Opioid Users [NA]
A clinical trial (NCT02647073) evaluating mobile monitoring of vital signs in individuals with opioid use disorder has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-21Clinical Trial Update: A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults [Phase 1]
This Phase 1 trial comparing plasma concentrations of a hydrocodone/acetaminophen tablet from a new formulation versus a marketed tablet, un…
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Prescription Opioid Effects in Abusers Versus Non-Abusers [Phase 2]
A Phase 2 study compares the effects of prescription opioids in abusers versus non-abusers. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-07-06Clinical Trial Update: Medications Development for Drug Abuse Disorders [Phase 1, Phase 2]
This update reports completed Phase 1 and Phase 2 trials of medications for opioid use disorder, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-05Clinical Trial Update: A Laboratory Model for Heroin Abuse Medications - 8 [Phase 2]
Phase 2 clinical trial update on a laboratory model for heroin abuse medications has completed. Sponsored by the New York State Psychiatric …
-
CLINICAL_TRIALS trial_result · 2017-06-29Clinical Trial Update: The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention [Phase 2, Phase 3]
This clinical trial update discusses the effectiveness of deep brain stimulation for preventing relapse in opioid use disorder, covering Pha…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Testosterone Replacement for Male Opioid Agonist Maintained Patients [Phase 1, Phase 2]
Phase 1/Phase 2 trial evaluating testosterone replacement in men on opioid agonist therapy with chronic pain and symptomatic hypogonadism; r…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration [Phase 2]
Phase 2 clinical trial update evaluating clomiphene citrate for treating low testosterone in men on chronic opioid therapy; the study comple…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Palonosetron and Hydroxyzine to Reduce Opioid Withdrawal [NA]
A completed clinical trial evaluated the combination of palonosetron and hydroxyzine to reduce opioid withdrawal symptoms; results have been…
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Buprenorphine in the Emergency Department [Phase 4]
A Phase 4 clinical trial evaluating buprenorphine in the emergency department for opioid withdrawal and opioid-use disorder has completed.
-
FDA approval · 2017-05-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for methadone hydrochloride submitted by VistaPharm, LLC. The action represents an additional regula…
-
FDA approval · 2017-05-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Ascend Laboratories, LLC)
FDA approves a supplemental application for methadone hydrochloride (generic) from Ascend Laboratories, LLC.
-
FDA approval · 2017-05-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Epic Pharma, LLC)
FDA approved a supplemental application for methadone hydrochloride from Epic Pharma, LLC, approving the generic formulation.
-
FDA approval · 2017-05-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Methadone Hydrochloride by Hikma Pharmaceuticals USA Inc., updating the product's approved i…
-
FDA approval · 2017-05-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc., documenting the acceptance of a sup…
-
FDA approval · 2017-05-26FDA Approved: METHADONE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for methadone hydrochloride from Hikma Pharmaceuticals USA Inc. to modify/update the product's appro…
-
FDA approval · 2017-05-23FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for buprenorphine and naloxone from Actavis Pharma, expanding its existing approval for opioid u…
-
FDA approval · 2017-05-23FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental (ANDA) application for a generic buprenorphine/naloxone product from Lannett Company, Inc.